ZORTRAX S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.204 PLN | +6.25% |
|
+1.75% | -33.98% |
| Sales 2021 | 20.08M 5M 6.86M | Sales 2022 | 40.15M 10M 13.71M | Capitalization | 68.1M 16.97M 23.25M |
|---|---|---|---|---|---|
| Net income 2021 | -6M -1.49M -2.05M | Net income 2022 | -8M -1.99M -2.73M | EV / Sales 2021 | 16.9 x |
| Net cash position 2021 | 3.05M 761K 1.04M | Net cash position 2022 | 2.73M 681K 933K | EV / Sales 2022 | 1.63 x |
| P/E ratio 2021 |
-50.2
x | P/E ratio 2022 |
-7.79
x | Employees | 75 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 40.51% |
More Fundamentals
* Assessed data
More news
| 1 day | +6.25% | ||
| 1 week | +1.75% | ||
| Current month | +6.25% | ||
| 1 month | +16.57% | ||
| 3 months | -18.73% | ||
| 6 months | -44.41% | ||
| Current year | -33.98% |
1 week
0.19
0.20
1 month
0.180.22
Current year
0.150.31
1 year
0.150.58
3 years
0.154.35
5 years
0.154.35
10 years
0.154.35
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 41 | 20-08-31 | |
Mariusz Babula
CEO | Chief Executive Officer | - | - |
Borowska Dorota
DFI | Director of Finance/CFO | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 48 | - | |
| Director/Board Member | 45 | - | |
Tomasz Supel
BRD | Director/Board Member | 41 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-02 | 0.204 | +6.25% | 344,751 |
| 24-04-30 | 0.192 | -2.44% | 397,364 |
| 24-04-29 | 0.1968 | -1.85% | 244,145 |
| 24-04-26 | 0.2005 | -3.14% | 281,419 |
End-of-day quote Warsaw S.E., May 01, 2024
More quotes
Zortrax SA, formerly Corelens SA, is a Poland-based company providing specialized solutions for the ophthalmic industry. The Company's business clients are public and private medical centers in Poland and the main product are intraocular lenses, which are used by doctors in cataract surgery. Other Company's products include surgical sets and disposable tools, viscoelastics and diagnostic equipment, also used by ophthalmologists during cataract surgery.
| 1st Jan change | Capi. | |
|---|---|---|
| -33.98% | 5.86M | |
| -3.79% | 184B | |
| -0.84% | 108B | |
| -3.75% | 67.8B | |
| +3.45% | 51.05B | |
| +9.04% | 44.67B | |
| +3.40% | 41.78B | |
| +3.21% | 26.78B | |
| +3.66% | 26.59B | |
| +15.23% | 25.86B |
- Stock Market
- Equities
- ZRX Stock
